Anatomic pathology also plays a vital role in research and contributes to the advancement of medical knowledge. By studying tissue samples from patients, pathologists can uncover new insights into the development, progression, and treatment of diseases. This knowledge contributes to the development of new diagnostic tools, therapeutic strategies, and targeted therapies.
In addition to its diagnostic and research functions, Anatomic Pathology is essential for disease management and surveillance. Pathologists collaborate with clinicians, surgeons, and other healthcare professionals to provide accurate and timely diagnoses, enabling appropriate treatment decisions. They also monitor disease progression through the examination of tissue samples taken during procedures such as biopsies or surgeries, assessing the effectiveness of treatment and providing valuable prognostic information.
Pathologists employ their expertise in histology, immunology, molecular biology, and genetics to examine tissue samples, interpret microscopic findings, and provide critical information for patient care. This field continues to evolve with technological advancements, allowing for more accurate and personalized diagnostic approaches. Anatomic pathology serves as a bridge between the laboratory and the clinic, playing a pivotal role in healthcare, research, and disease management.
According to the new market research report " Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021", published by MarketsandMarkets™, The anatomic pathology market was valued at USD 16.2 Billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 Billion in 2021.Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145Anatomic Pathology Market segmented into :- On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications.
The growth in this segment primarily attributed to increasing prevalence of chronic diseases.- On the basis of product and service, the market is segmented into instruments, consumables, and services.
This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.Get Sample Copy of This Report:https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).Browse and in-depth TOC on "anatomic pathology market"80 – Tables32 – Figures129 – PagesGeographically, the anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).
The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this Anatomical pathology market.
